FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2154950095> ?p ?o ?g. }

• W2154950095 endingPage "843" @default.
• W2154950095 startingPage "833" @default.
• W2154950095 abstract "Summary. Development of therapeutic strategies for patients with chronic hepatitis C who experience virological breakthrough, relapse or nonresponse lag behind those for treatment‐naïve patients. The probability of a previously treated patient responding to re‐treatment depends on the nature of the previous regimen, the magnitude of the response to previous treatment and the patient’s characteristics. Relapsers have higher sustained virological response rates than nonresponders when re‐treated with pegylated interferon plus ribavirin. Re‐treatment of nonresponders to pegylated interferon plus ribavirin with the standard 48‐week regimen resulted in an approximate 6% sustained response rate in the EPIC‐3 program. In the REPEAT trial, the sustained response rate was significantly higher in nonresponders to pegylated interferon alfa‐2b (12 kD) plus ribavirin randomized to 72 weeks of peginterferon alfa‐2a (40 kD) plus ribavirin, compared with a 48‐week regimen (16% vs 8%, P = 0.0006). Based on available data, extended treatment is the best option for these individuals. Undetectable viral RNA at week 12 is an important criterion for re‐treatment in the REPEAT and EPIC studies. Maintenance therapy with pegylated interferon is generally ineffective in nonresponders and cannot be recommended. Directly acting antivirals may increase response rates and the burden of adverse events when combined with the standard of care, but will not be available for some years. In conclusion, after careful evaluation of an individual’s benefit–risk ratio, a 72‐week regimen is the preferred strategy for optimizing sustained response rates in patients who have not responded to the standard of care, provided that viral RNA is undetectable at week 12 of re‐treatment." @default.
• W2154950095 created "2016-06-24" @default.
• W2154950095 creator A5002183557 @default.
• W2154950095 creator A5018963659 @default.
• W2154950095 creator A5024836953 @default.
• W2154950095 date "2009-11-04" @default.
• W2154950095 modified "2023-10-16" @default.
• W2154950095 title "Management of chronic hepatitis C patients who have relapsed or not responded to pegylated interferon alfa plus ribavirin" @default.
• W2154950095 cites W1972807219 @default.
• W2154950095 cites W1978992694 @default.
• W2154950095 cites W1989022528 @default.
• W2154950095 cites W1996049094 @default.
• W2154950095 cites W1999155210 @default.
• W2154950095 cites W2001854427 @default.
• W2154950095 cites W2009335842 @default.
• W2154950095 cites W2010855805 @default.
• W2154950095 cites W2011235168 @default.
• W2154950095 cites W2013010588 @default.
• W2154950095 cites W2024043429 @default.
• W2154950095 cites W2024049300 @default.
• W2154950095 cites W2024258010 @default.
• W2154950095 cites W2027545702 @default.
• W2154950095 cites W2028764287 @default.
• W2154950095 cites W2038576929 @default.
• W2154950095 cites W2039345617 @default.
• W2154950095 cites W2058720438 @default.
• W2154950095 cites W2063783484 @default.
• W2154950095 cites W2070310839 @default.
• W2154950095 cites W2071277949 @default.
• W2154950095 cites W2071586067 @default.
• W2154950095 cites W2076600280 @default.
• W2154950095 cites W2085244735 @default.
• W2154950095 cites W2085261733 @default.
• W2154950095 cites W2086667773 @default.
• W2154950095 cites W2090439540 @default.
• W2154950095 cites W2098036743 @default.
• W2154950095 cites W2105605655 @default.
• W2154950095 cites W2112876622 @default.
• W2154950095 cites W2113864802 @default.
• W2154950095 cites W2115869094 @default.
• W2154950095 cites W2119156880 @default.
• W2154950095 cites W2127685726 @default.
• W2154950095 cites W2133580842 @default.
• W2154950095 cites W2134194979 @default.
• W2154950095 cites W2146956830 @default.
• W2154950095 cites W2150164306 @default.
• W2154950095 cites W2152870084 @default.
• W2154950095 cites W2163559237 @default.
• W2154950095 cites W2039381938 @default.
• W2154950095 doi "https://doi.org/10.1111/j.1365-2893.2009.01218.x" @default.
• W2154950095 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19889142" @default.
• W2154950095 hasPublicationYear "2009" @default.
• W2154950095 type Work @default.
• W2154950095 sameAs 2154950095 @default.
• W2154950095 citedByCount "24" @default.
• W2154950095 countsByYear W21549500952012 @default.
• W2154950095 countsByYear W21549500952013 @default.
• W2154950095 countsByYear W21549500952014 @default.
• W2154950095 countsByYear W21549500952016 @default.
• W2154950095 countsByYear W21549500952022 @default.
• W2154950095 crossrefType "journal-article" @default.
• W2154950095 hasAuthorship W2154950095A5002183557 @default.
• W2154950095 hasAuthorship W2154950095A5018963659 @default.
• W2154950095 hasAuthorship W2154950095A5024836953 @default.
• W2154950095 hasConcept C126322002 @default.
• W2154950095 hasConcept C168563851 @default.
• W2154950095 hasConcept C197934379 @default.
• W2154950095 hasConcept C203014093 @default.
• W2154950095 hasConcept C2522874641 @default.
• W2154950095 hasConcept C2776178377 @default.
• W2154950095 hasConcept C2776455275 @default.
• W2154950095 hasConcept C2776461080 @default.
• W2154950095 hasConcept C2780040827 @default.
• W2154950095 hasConcept C2781413609 @default.
• W2154950095 hasConcept C2909179924 @default.
• W2154950095 hasConcept C3020491458 @default.
• W2154950095 hasConcept C71924100 @default.
• W2154950095 hasConcept C90924648 @default.
• W2154950095 hasConceptScore W2154950095C126322002 @default.
• W2154950095 hasConceptScore W2154950095C168563851 @default.
• W2154950095 hasConceptScore W2154950095C197934379 @default.
• W2154950095 hasConceptScore W2154950095C203014093 @default.
• W2154950095 hasConceptScore W2154950095C2522874641 @default.
• W2154950095 hasConceptScore W2154950095C2776178377 @default.
• W2154950095 hasConceptScore W2154950095C2776455275 @default.
• W2154950095 hasConceptScore W2154950095C2776461080 @default.
• W2154950095 hasConceptScore W2154950095C2780040827 @default.
• W2154950095 hasConceptScore W2154950095C2781413609 @default.
• W2154950095 hasConceptScore W2154950095C2909179924 @default.
• W2154950095 hasConceptScore W2154950095C3020491458 @default.
• W2154950095 hasConceptScore W2154950095C71924100 @default.
• W2154950095 hasConceptScore W2154950095C90924648 @default.
• W2154950095 hasIssue "12" @default.
• W2154950095 hasLocation W21549500951 @default.
• W2154950095 hasLocation W21549500952 @default.
• W2154950095 hasOpenAccess W2154950095 @default.
• W2154950095 hasPrimaryLocation W21549500951 @default.
• W2154950095 hasRelatedWork W2004479501 @default.

• next